Literature DB >> 27853165

Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study.

Cesare Cuspidi1,2, Carla Sala3, Anna Casati1, Michele Bombelli1, Guido Grassi1,4, Giuseppe Mancia1.   

Abstract

Because subclinical alterations in cardiovascular structure reflect cumulative damage induced by risk factors and represent an intermediate stage between risk factor exposure and cardiovascular events, this damage is regarded as a marker of increased cardiovascular risk in different clinical settings, including the general population. The Pressioni Monitorate e Loro Associazioni (PAMELA) is an originally designed research study aimed at assessing the normal values and prognostic significance of ambulatory and home blood pressure in a representative sample of the Northern Italian general population. Because the study protocol included the collection of electrocardiographic (ECG) and echocardiographic (ECHO) data, the prevalence and clinical correlates, as well as the prognostic value of subclinical cardiac alterations, have been extensively investigated. This article is a review of the findings of the PAMELA study regarding the clinical aspects and prognostic significance of cardiac abnormal phenotypes such as left ventricular hypertrophy, left atrial dilatation and aortic root dilation.

Entities:  

Mesh:

Year:  2016        PMID: 27853165     DOI: 10.1038/hr.2016.153

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  55 in total

1.  The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk.

Authors:  Pamela S Douglas
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.

Authors:  W B Kannel; T Gordon; D Offutt
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

3.  Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study).

Authors:  R Sega; G Trocino; A Lanzarotti; S Carugo; G Cesana; R Schiavina; F Valagussa; M Bombelli; C Giannattasio; A Zanchetti; G Mancia
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

4.  Effect of hypertension on aortic root size and prevalence of aortic regurgitation.

Authors:  M Kim; M J Roman; M C Cavallini; J E Schwartz; T G Pickering; R B Devereux
Journal:  Hypertension       Date:  1996-07       Impact factor: 10.190

5.  Left atrial enlargement in essential hypertension: role in the assessment of subclinical hypertensive heart disease.

Authors:  Alberto Milan; Elisabetta Puglisi; Corrado Magnino; Diego Naso; Sara Abram; Eleonora Avenatti; Franco Rabbia; Paolo Mulatero; Franco Veglio
Journal:  Blood Press       Date:  2011-10-13       Impact factor: 2.835

Review 6.  Left ventricular hypertrophy and clinical outcomes in hypertensive patients.

Authors:  Luis M Ruilope; Roland E Schmieder
Journal:  Am J Hypertens       Date:  2008-03-13       Impact factor: 2.689

7.  A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study.

Authors:  Michel G Khouri; Ronald M Peshock; Colby R Ayers; James A de Lemos; Mark H Drazner
Journal:  Circ Cardiovasc Imaging       Date:  2010-01-08       Impact factor: 7.792

Review 8.  Echocardiographic aortic root dilatation in hypertensive patients: a systematic review and meta-analysis.

Authors:  Michele Covella; Alberto Milan; Silvia Totaro; Cesare Cuspidi; Annalisa Re; Franco Rabbia; Franco Veglio
Journal:  J Hypertens       Date:  2014-10       Impact factor: 4.844

9.  Left atrial volume and geometry in healthy aging: the Cardiovascular Health Study.

Authors:  Gerard P Aurigemma; John S Gottdiener; Alice M Arnold; Marcello Chinali; Jeffrey C Hill; Dalane Kitzman
Journal:  Circ Cardiovasc Imaging       Date:  2009-05-11       Impact factor: 7.792

10.  Left atrial dimension is related to blood pressure variability in newly diagnosed untreated hypertensive patients.

Authors:  Franco Cipollini; Enrica Arcangeli; Giuseppe Seghieri
Journal:  Hypertens Res       Date:  2016-03-24       Impact factor: 3.872

View more
  6 in total

Review 1.  Big Data and Blood Pressure Control: Insights from the PAMELA and BP-CARE Study Cohorts.

Authors:  M Bombelli; Rita Facchetti; Giuseppe Mancia; Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2018-07-26       Impact factor: 5.369

Review 2.  Hypertensive Heart Failure in Asia.

Authors:  Helsi Rismiati; Hae-Young Lee
Journal:  Pulse (Basel)       Date:  2021-10-11

3.  Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study.

Authors:  Daisuke Kamimura; Takeki Suzuki; Wanmei Wang; Matthew deShazo; John E Hall; Michael D Winniford; Iftikhar J Kullo; Thomas H Mosley; Kenneth R Butler; Michael E Hall
Journal:  Hypertens Res       Date:  2018-06-15       Impact factor: 3.872

Review 4.  Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review.

Authors:  Francesca Miceli; Vivianne Presta; Barbara Citoni; Flaminia Canichella; Ilaria Figliuzzi; Andrea Ferrucci; Massimo Volpe; Giuliano Tocci
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-06       Impact factor: 3.738

5.  Home sphygmomanometers can help in the control of blood pressure: a nationwide field survey.

Authors:  Tekin Akpolat; Mustafa Arici; Sule Sengul; Ulver Derici; Sukru Ulusoy; Sehsuvar Erturk; Yunus Erdem
Journal:  Hypertens Res       Date:  2018-03-19       Impact factor: 3.872

6.  The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings.

Authors:  Alberto Mazza; Danyelle M Townsend; Gioia Torin; Laura Schiavon; Alessandro Camerotto; Gianluca Rigatelli; Stefano Cuppini; Pietro Minuz; Domenico Rubello
Journal:  Biomed Pharmacother       Date:  2020-08-21       Impact factor: 6.529

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.